Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (åpner nytt vindu)

Brady KM, Easley RB, Tobias JD.

Kilde‎: Paediatr Anaesth 2006;16(10):1042-6.

Arkiv‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (åpner nytt vindu)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (åpner nytt vindu)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Kilde‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Arkiv‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (åpner nytt vindu)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (åpner nytt vindu)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Kilde‎: Pediatrics 2002;110(1 Pt 1):169-71.

Arkiv‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (åpner nytt vindu)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (åpner nytt vindu)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Kilde‎: Paediatr Drugs 2017;19(1):53-8.

Arkiv‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (åpner nytt vindu)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (åpner nytt vindu)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Kilde‎: J Perinatol 2011;31(3):188-92.

Arkiv‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (åpner nytt vindu)

Use of recombinant factor VIIa in infants with severe coagulopathy. (åpner nytt vindu)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Kilde‎: J Perinatol 2004;24(5):310-1.

Arkiv‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (åpner nytt vindu)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (åpner nytt vindu)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Kilde‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Arkiv‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (åpner nytt vindu)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (åpner nytt vindu)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Kilde‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Arkiv‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (åpner nytt vindu)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (åpner nytt vindu)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Kilde‎: Paediatr Anaesth 2009;19(4):364-70.

Arkiv‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (åpner nytt vindu)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (åpner nytt vindu)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Kilde‎: Spine 2004;29(12):1384-7.

Arkiv‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (åpner nytt vindu)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (åpner nytt vindu)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Kilde‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Arkiv‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (åpner nytt vindu)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (åpner nytt vindu)

Olomu N, Kulkarni R, Manco-Johnson M.

Kilde‎: J Perinatol 2002;22(8):672-4.

Arkiv‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (åpner nytt vindu)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (åpner nytt vindu)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Kilde‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Arkiv‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (åpner nytt vindu)